Congresses and Events

The SYNERGY™ Stent: complete revascularization solutions in complex PCI

Webcast: The SYNERGY™ Stent: complete revascularization solutions in complex PCI Webcast: The SYNERGY™ Stent: complete revascularization solutions in complex PCI

In this Symposium from EuroPCR 2017, a panel of experts discuss about the recommended requirement for use of DES in clinical practice and the potential benefits of bioabsorbable polymer DES in high-bleeding risk patients. Watch the webcast and learn how the SYNERGY™ stent is being used in complex patient subsets.

Learn more

LOTUS™ Valve: expanding treatment options in real-world practice

Webcast: LOTUS™ Valve: expanding treatment options in real-world practice Webcast: LOTUS™ Valve: expanding treatment options in real-world practice

LOTUS™ Valve expands treatment options in real-world practice. From EuroPCR 2017, a webcast dedicated to the LOTUS™ program, reviewing a range topics from our trial data to some really good clinical examples.

Learn more

Boston Scientific has closed Symetis Acquisition

LOTUS™ Valve Platform and ACURATE TA™ LOTUS™ Valve Platform and ACURATE TA™

Boston Scientific Corporation has announced the close of its acquisition for $435 million of Symetis SA. With the completion of the acquisition, the Company will immediately begin selling the ACURATE TA™ and ACURATE neo™/TF™ valve systems, expanding its Structural Heart Portfolio and increasing the Offerings for the treatment of Patients with Valvular Heart Disease.

Learn more

Top